Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal tissue complication probabilities: variable dose per fraction.

J T Lyman1

  • 1Lawrence Berkeley Laboratory, University of California, Berkeley 94720.

International Journal of Radiation Oncology, Biology, Physics
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HEAVY-PARTICLE IONIZATION (H, HE, LI, B, C, N, O, F, NE, AR) AND THE PROLIFERATIVE CAPACITY OF NEOPLASTIC CELLS IN VIVO. UCRL-11033.

UCRL [reports]. U.S. Atomic Energy Commission·2014
Same author

PRELIMINARY REPORT ON HISTOPATHOLOGICAL CHANGES IN BRAIN FOLLOWING HEAVY-PARTICLE IRRADIATION. UCRL-11033.

UCRL [reports]. U.S. Atomic Energy Commission·2014
Same author

USE OF THE BRAGG PEAK FOR BRAIN-TUMOR THERAPY. UCRL-11184.

UCRL [reports]. U.S. Atomic Energy Commission·2014
Same author

THE RELATIVE EFFICIENCY OF HIGH-LET RADIATIONS (BRAGG-PEAK LITHIUM IONS) ON NORMAL RABBIT SKIN, USING INTEGRAL DOSE AS A BASIS FOR COMPARISON. UCRL-11387.

UCRL [reports]. U.S. Atomic Energy Commission·2014
Same author

BONE-GROWTH DISTURBANCE AS AN INDEX FOR R.B.E. INVESTIGATIONS - PRELIMINARY OBSERVATIONS. UCRL-11387.

UCRL [reports]. U.S. Atomic Energy Commission·2014
Same author

Technical note: using calcium carbonate as an osmolar control treatment for acid-base studies in horses.

Journal of animal science·2001
Same journal

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same journal

Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

International journal of radiation oncology, biology, physics·2026
Same journal

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

International journal of radiation oncology, biology, physics·2026
Same journal

Gastrointestinal Motility-Induced Interplay in Pancreas Proton Therapy: Motion Simulation and Dosimetric Impact.

International journal of radiation oncology, biology, physics·2026
Same journal

Intra-fractional Voxel-wise Anatomical Motion Tracking Guided by Multimodal Respiratory Surrogates in Radiotherapy: Framework Development and Multi-Center Validation.

International journal of radiation oncology, biology, physics·2026
Same journal

A Gaussian-based planning approach for robust dose-escalated stereotactic body proton therapy.

International journal of radiation oncology, biology, physics·2026
See all related articles

New tools optimize radiation therapy plans by estimating tumor control and normal tissue complication probability (NTCP). This study assesses how varying daily radiation doses impact NTCP calculations for improved treatment accuracy.

Area of Science:

  • Radiation oncology
  • Medical physics
  • Radiotherapy planning

Background:

  • 3D treatment planning generates vast data, necessitating advanced tools for plan evaluation and optimization.
  • Estimating local tumor control and normal tissue complication probability (NTCP) are key advancements.
  • Current NTCP models rely on clinical tolerance doses, typically for 2 Gy/fraction, 5 fractions/week schedules.

Purpose of the Study:

  • To evaluate the maximum expected change in Normal Tissue Complication Probability (NTCP).
  • To assess NTCP variations when normal tissues receive doses at different dose-per-fraction rates compared to the target volume.
  • To understand the impact of varied daily fraction delivery on NTCP predictions.

Main Methods:

  • Analysis of Normal Tissue Complication Probability (NTCP) models.

Related Experiment Videos

  • Comparison of NTCP calculations under standard versus altered dose-per-fraction scenarios.
  • Evaluation of dose delivery variations between target volumes and surrounding normal structures.

    • Main Results:

    • Identified potential discrepancies in NTCP predictions when dose per fraction differs between target and normal tissues.
    • Quantified the maximum expected change in NTCP under non-standard fractionation schedules.
    • Highlighted the sensitivity of NTCP calculations to variations in daily radiation dose delivery.

    Conclusions:

    • Standard NTCP models may require adjustments when non-uniform fractionation is employed.
    • The study underscores the importance of considering dose per fraction variations for accurate NTCP assessment.
    • Findings support the development of more robust tools for optimizing radiotherapy plans considering complex fractionation schemes.